Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue. - sprookjes - yvandenbroek - TriplyDB

Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.

Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.

http://www.wikidata.org/entity/Q34338236

about

Research priorities in sarcomeric cardiomyopathies Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue.FHL2 expression and variants in hypertrophic cardiomyopathy.Probing muscle ankyrin-repeat protein (MARP) structure and function Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents.Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction.Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing Multifunctional protein: cardiac ankyrin repeat protein MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy.199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.Differentially expressed genes in PPARγ-deficient MSCs.Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening.Rat engineered heart tissue: a novel tool in the safety pharmacology toolkit?S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue Characterization of zebrafish (Danio rerio) muscle ankyrin repeat proteins reveals their conserved response to endurance exercise

P2860

Q27694507-6EC826D2-1F73-4F44-8E4F-3ACEF7E12592 Q28253008-2A72485B-1A3F-453F-BE90-6AC6C3B5CFE9 Q34000083-03FC5E82-DDD9-4CD3-96D2-651AAAE9128B Q34161831-A420BB3B-A17A-467D-947A-423907CB46B9 Q34430364-CA633539-2532-49EE-B2AE-E1F3FC2575AD Q34433678-F795F74E-1C34-41C1-81DD-660FCD2B49F4 Q34453986-773501CC-1BA6-43FC-A9B7-6F4138A1E51B Q34467093-8B7BB78C-134F-4E32-9C77-7798D879511B Q34780816-04BFD4B7-435C-4608-9442-68237B35C73F Q36287303-7E480A57-D5F5-4E04-95BE-F527823D05A0 Q36906090-878FD242-FF41-42FC-8C03-EAA6A62806CA Q37061259-1A738D7B-6DF0-42C7-A8A0-F9AF34656AAE Q37555727-B966E835-69C9-4108-AD10-9145D0FA61EB Q38642592-46A3BE4E-D3A2-40E8-9B03-43232EB1CE8B Q46375849-D74A5DDD-6067-4784-B052-EF4034130689 Q53450193-E2386D90-AC1E-4E7F-B1A1-EA5E5963E00F Q57072975-7A0FD1BB-20F8-43C6-A900-E65090B62CBE Q58699188-773AD579-EC17-4E28-AC5C-91991CF8BA24

P2860

Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.

http://www.wikidata.org/entity/Q34338236

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@ast

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@en

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@nl

type

label

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@ast

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@en

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@nl

prefLabel

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@ast

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@en

Impact of ANKRD1 mutations ass ...... rs of engineered heart tissue.

@nl

P1433

Q34338236-FA49333E-9D93-4683-83CC-DD5070596C89

P1476

Q34338236-C3322995-1022-494C-BF48-F0C0CD18E264

P2093

Q34338236-26369896-CDF7-497C-8C43-70B91420A054

Q34338236-3DDC5B28-B7AA-472F-9C94-AC3C2CD53043

Q34338236-40DFF25B-03A6-4692-B75B-A41207D1EDF5

Q34338236-537D581A-555C-4B6F-B495-601255F8785E

Q34338236-625FF708-AE5A-4155-A0C3-D5AEF5559A78

Q34338236-7314BE65-DA4E-4187-A059-77E03CB129FD

Q34338236-BA26490C-9704-4C5E-814D-07211A6B2DD9

Q34338236-C650DBE3-2FB4-4E86-8892-E7886B64BAC6

P2860

Q34338236-05F5B86F-01D4-4E3A-BA36-E026FE2112D2

Q34338236-20BC1F16-63B9-44BC-BB49-B0679B048BB4

Q34338236-2A6B0DFE-0EAF-4D44-883E-8A6BDA053665

Q34338236-2EF1D46C-1B26-4A51-A692-1AE888BE291F

Q34338236-307A21DE-72F8-4FEA-9EBE-8BED154BD3B4

Q34338236-34CAC9AF-8ADE-4638-8C8A-02BE747731ED

Q34338236-3587CF08-4476-4FE7-8F9B-64D93B9A4618

Q34338236-3ADDF827-7443-4A25-BB0E-51C607A9B1CE

Q34338236-46B9B736-2CCF-4ADB-BDA7-57A9289A09C8

Q34338236-4D7CAA91-C501-499A-AC06-20F562E9CFB1

P2888

Q34338236-FFCF6CB9-4C63-4A25-BE50-B4BFD542756C

P304

Q34338236-FCEE9BAD-E87C-4061-B65B-786E12614487

P31

Q34338236-DA8177E6-953F-4D0C-8B34-343DDD4DADA9

P356

Q34338236-C094248E-8B18-4BCB-AD35-A37E082626A8

P433

Q34338236-75FE31C9-53AA-4F95-8F15-F80863043FB9

P478

Q34338236-FA63E588-1949-4834-B71F-95176AAAD1AF

P50

Q34338236-51B3488B-0004-44D8-820C-9E31D2DF0E8F

P577

Q34338236-8F32EF25-9A7A-48CB-8701-C8E47558243C

P5875

Q34338236-7D55AAE9-839D-44CB-A699-A448608F2A1C

P6179

Q34338236-BD0780BC-9ABE-40A7-9683-12798E51123B

P698

Q34338236-46B7ED31-0642-47A6-B502-3A1831528C46

P356

S00395-013-0349-X

P1433

Basic Research in Cardiology

P1476

Impact of ANKRD1 mutations ass ...... ers of engineered heart tissue

@en

P2093

Akinori Kimura

http://www.w3.org/2001/XMLSchema#string

Alexandra Eder

http://www.w3.org/2001/XMLSchema#string

Arne Hansen

http://www.w3.org/2001/XMLSchema#string

Ingke Braren

http://www.w3.org/2001/XMLSchema#string

Lucie Carrier

http://www.w3.org/2001/XMLSchema#string

Silke Reischmann

http://www.w3.org/2001/XMLSchema#string

Takuro Arimura

http://www.w3.org/2001/XMLSchema#string

Thomas Eschenhagen

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy

Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies

The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules

Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure

A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-κB pathway in skeletal muscle

Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene

Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction

Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes

Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice

P2888

s00395-013-0349-x

P304

349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00395-013-0349-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Crocini

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236188587

http://www.w3.org/2001/XMLSchema#string

P6179

1017687734

http://www.w3.org/2001/XMLSchema#string

P698

23572067

http://www.w3.org/2001/XMLSchema#string